Skip to main content
Top

Annals of Hematology

Issue 2/2009

Content (15 Articles)

Review Article

Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Angelika Böhme, Markus Ruhnke, Dieter Buchheidt, Oliver A. Cornely, Herrmann Einsele, Ruxandra Enzensberger, Holger Hebart, Werner Heinz, Christian Junghanss, Meinolf Karthaus, William Krüger, Utz Krug, Thomas Kubin, Olaf Penack, Dietmar Reichert, Stefan Reuter, Gerda Silling, Thomas Südhoff, Andrew J. Ullmann, Georg Maschmeyer

Original Article

Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified”

Yuna Lee, Ji Eun Uhm, Hui-Young Lee, Min Jae Park, Hyeongsu Kim, Suk Joong Oh, Jun Ho Jang, Kihyun Kim, Chul Won Jung, Yong Chan Ahn, Keunchil Park, Young Hyeh Ko, Won Seog Kim

Original Article

Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab

Thomas Elter, Janne J. Vehreschild, John Gribben, Oliver A. Cornely, Andreas Engert, Michael Hallek

Original Article

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma

Lars Fischer, Agnieszka Korfel, Philipp Kiewe, Martin Neumann, Kristoph Jahnke, Eckhard Thiel

Original Article

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

Andrea Camera, Ciro R. Rinaldi, Salvatore Palmieri, Nicola Cantore, Giuseppina Mele, Vincenzo Mettivier, Eustachio Miraglia, Lucia Mastrullo, Francesco Grimaldi, Luigia Luciano, Anna Guerriero, Bruno Rotoli, Felicetto Ferrara

Original Article

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

Guo-Rui Ruan, Jin-Lan Li, Ya-Zhen Qin, Ling-Di Li, Min Xie, Yan Chang, Yan Zhang, Yan-Rong Liu, Bin Jiang, Shan-Shan Chen, Xiao-Jun Huang

Letter to the Editor

Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

R. Trappe, H. Riess, I. Anagnostopoulos, R. Neuhaus, B. C. Gärtner, H. Pohl, H. P. Müller, S. Jonas, M. Papp-Vary, S. Oertel

Letter to the Editor

Splenic marginal zone lymphoma with Evans’ syndrome, autoimmunity, and peripheral gamma/delta T cells

Ricardo García-Muñoz, Paula Rodriguez-Otero, Carlota Pegenaute, Juana Merino, Juan Jakes-Okampo, Luis Llorente, Maurizio Bendandi, Carlos Panizo

Letter to the Editor

Erythropoietin for hemoglobin H disease

Olga M. Fortenko, Gretchen J. Schaef Johns, Ganesh C. Kudva

Letter to the Editor

Multiple myeloma presenting with spinal cord compression during pregnancy

John Quinn, Neil Rabin, Manuel Rodriguez-Justo, David Choi, Kwee Yong

Letter to the Editor

Hepatotoxicity as a rare but serious side effect of Thalidomide

Eric Levesque, Marc Bradette

Letter to the Editor

Non-nasal natural killer cell lymphoma: not non-nasal after all

Eric Tse, Rock Leung, Pek-Lan Khong, Wing-Hung Lau, Yok-Lam Kwong

Letter to the Editor

Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination?

Carlo Visco, Enrico Marchioni, Fabrizio Pomponi, Pasquale Ferrante, Serena Delbue, Gianpietro Pellizzer, Francesco Rodeghiero

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.